Schedule 13G ownership disclosure
Strongbridge Biopharma plc
Security class unavailable · CUSIP: G85347105
Event date: 2017-09-12
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-17-006894
- Form type
- SC 13G
- Filer
- ARMISTICE CAPITAL, LLC
- CIK
- CIK 1601086
- Filed
- Sep 22, 2017
- Reporting period
- Sep 12, 2017
- Description
- Schedule 13G beneficial ownership